The BRIP1 gene helps repair damaged DNA, which is one way your cells protect themselves as they grow and divide. This gene plays an important role in keeping that repair process steady, so if it does not work well, DNA damage can build up over time. Some inherited variants in the BRIP1 gene are linked to a higher risk of ovarian cancer, and certain rarer variants can cause a childhood condition called Fanconi anemia when both copies of the gene are affected. BRIP1 is important in hereditary cancer testing, although it is less widely known than the BRCA1 gene or the BRCA2 gene.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or manage processes in the body. Some genes carry the instructions for producing proteins, the parts of cells that do much of the work. Other genes mainly help direct when certain processes take place, where they do, and how strongly they operate. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
BRIP1Gene function
What if the gene works
The BRIP1 gene helps cells repair damaged DNA, especially during cell division. Its protein works with BRCA1 and other repair proteins to keep chromosomes stable and lower the buildup of DNA errors.
Risk
What if the gene does not work
Variants in the BRIP1 gene can raise ovarian cancer risk, while two altered copies can cause Fanconi anemia, a childhood condition affecting growth, bone marrow, and cancer risk. Effects can range from milder risk changes to earlier, broader symptoms.
Treatment
What does that mean for your treatment
A pathogenic variant in the BRIP1 gene can help guide treatment in some advanced prostate cancers, where guidelines include PARP inhibitors such as olaparib for eligible people with BRIP1-related DNA repair changes. BRIP1 status may also shape management by supporting discussions about risk reducing removal of the fallopian tubes and ovaries at guideline-based ages. BRIP1-specific drug choices are less clearly established in most other settings.
Conditions associated with BRIP1
Gene function
What if the gene works
Every day, your cells need to copy and repair DNA while keeping the instruction code readable. The BRIP1 gene supports that work by partnering with other repair proteins, including BRCA1. Understanding how the BRIP1 gene works can make it easier to see how your cells stay healthy over time.
One of the main jobs of the BRIP1 gene is to help repair damaged DNA. Its protein works with BRCA1 and other repair helpers so broken DNA can be handled in an orderly way.
The BRIP1 gene makes a protein that can unwind small stretches of DNA, a bit like opening a zipper. This gives repair and copying tools access to the genetic instructions when cells are doing routine maintenance.
During cell division, the BRIP1 gene helps cells manage damage that can stall DNA copying. This supports smoother progress through the copying process and helps maintain stable chromosomes.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the BRIP1 gene can alter the protein's shape, stability, or key working regions, which may reduce helicase activity, weaken BRCA1 binding, or create a shortened protein the cell breaks down. The functional effect of BRIP1 gene variants ranges from milder changes that partly lower DNA repair to more severe loss of function variants that stop it almost completely, which can be linked to a stronger inherited cancer risk and, when both copies are affected, earlier and broader features.
How variants are linked to conditions
Pathogenic variants in the BRIP1 gene are linked to hereditary ovarian cancer risk and are a well-established cause of increased ovarian cancer susceptibility in some families. Carrying one pathogenic BRIP1 variant raises risk, but it does not mean cancer will definitely develop. When a person inherits pathogenic variants in both copies of the BRIP1 gene, this can cause Fanconi anemia, a rare inherited condition that usually begins in childhood.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are found throughout the general population. Most do not directly affect health and are simply part of normal human variation. For many genes, having a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
If you carry a harmful BRIP1 variant, your risk is mainly higher for ovarian cancer, and your family history of ovarian, breast, or related cancers can further shape your personal risk. There is not enough evidence to say that lifestyle changes specifically lower BRIP1-related cancer risk, so risk planning usually centers on age and family history.
Inheritance of BRIP1 variants
The inheritance pattern for BRIP1-related conditions depends on the specific health issue involved. For inherited cancer risk linked to the BRIP1 gene, the pattern is usually autosomal dominant, which means a parent with the variant can pass it to each child with a 50% chance. For Fanconi anemia caused by variants in the BRIP1 gene, the pattern is autosomal recessive, so a child must inherit one altered copy from each parent. In practical terms, how BRIP1 gene variants are inherited can differ within the same family depending on whether one or two copies are involved.
What does my BRIP1 result mean for my family?
A BRIP1 result can matter for close relatives because some BRIP1 changes can be passed down in families, and parents, brothers, sisters, and adult children may also carry the same change. For the cancer-risk form, one changed copy can run through a family, so first-degree relatives may wish to learn whether they carry it too. BRIP1 is also linked to a separate, rarer condition only when a child inherits changed copies from both parents, so family implications depend on which kind of BRIP1 result was found.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the BRIP1 gene uses a blood or saliva sample to read the gene’s DNA code. A lab looks for inherited changes and reports whether a variant is found, not found, or uncertain. Testing can check for a known family variant or include the BRIP1 gene as part of a broader inherited cancer panel.
When should I consider getting a genetic test?
Consider BRIP1 testing if you have ovarian cancer, have close relatives with ovarian cancer, or have a family member with a known BRIP1 gene change. It may help clarify whether cancer risk runs in the family and can guide care for you and relatives.
A genetic result is only one part of your health story
A genetic result may offer useful insight, yet the amount it can tell you varies by the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This happens because inherited differences can change how the body breaks down a drug, moves it through the body, or responds at its target. As a result, the same treatment may work better for some people, have less effect in others, or cause more side effects in some than in others.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may not work the same way for everyone. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the BRIP1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in routine medication response, so general questions about medicines or side effects are best discussed with your doctor. BRIP1 is being studied in cancer care because changes in genes that help fix damaged DNA may affect how some cancer treatments work, but this is not a routine guide for everyday prescribing.
History
The BRIP1 gene entered the scientific literature in the early 2000s, when researchers identified it as a protein partner of the BRCA1 gene during work on inherited breast and ovarian cancer. Building on this early work, scientists uncovered more about the gene. They later found that inherited harmful variants in the BRIP1 gene can also cause a form of Fanconi anemia, a rare condition that affects DNA repair and bone marrow function, when both copies are affected. This linked the gene to two major fields at once: cancer genetics and rare inherited conditions. Over time, studies clarified that some people carrying a single harmful BRIP1 variant have a higher risk of ovarian cancer. That history made the BRIP1 gene an established part of modern hereditary cancer testing.